SECRETARY OF HEALTH AND HUMAN SERVICES (Xavier Becerra)

Letters

Revise and extend FDA user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, S5171, S5172, S5173, S5174, S5175, S5176, S5177 [28SE]

Statements

FDA User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products Goals and Procedures, S5177–S5220 [28SE]